menu search

Global assets in spot bitcoin etfs hit $4.16 billion

LONDON, 4th November, 2023 (WAM) — Global assets invested in exchange-traded funds (ETFs) tied to the spot price of bitcoin now total US$4.16 billio...

November 4, 2023, 6:44 pm

Gbp/usd price analysis: pound holds steady after boe’s pause

The pound showed resilience following the Bank of England’s decision to hold rates. The BoE signaled no imminent intention of cutting rates. There a...

November 4, 2023, 4:59 pm

: palantir quickly reverses higher toward a 3-month high, best 4-day gain in six months

Shares of Palantir Technologies Inc. PLTR quickly reversed an early pullback to power up 4.0% toward a three-month high in morning trading. The rally ...

November 4, 2023, 4:29 pm

: 10-year yield heads for biggest weekly decline in a year after october jobs report

The benchmark 10-year yield dropped 16 basis points to 4.5% on Friday after data showed the U.S. created a fewer-than-expected 150,000 new jobs for Oc...

November 4, 2023, 4:29 pm

‘gold rush’: fred lewis on his shock return to show & decision to quit mining

In a surprising turn, fans saw a familiar face return during the November 3 episode of Gold Rush. It was Fred Lewis. The military veteran was primaril...

November 4, 2023, 1:14 pm

Morgan stanley: grab a 6.5% dividend yield from preferred shares

Morgan Stanley's Q3 financial results showed a decrease in wealth management revenue but higher margins. The bank only needed 6% of its net income to ...

November 4, 2023, 11:40 am

Berkshire hathaway's cash hoard hit a record. here are 4 earnings highlights

Warren Buffett's Berkshire Hathaway Inc. (BRK.A, BRK.B) reported its third-quarter earnings Saturday, which showed a net loss of $12.77 billion but t...

November 4, 2023, 10:00 am

Warren buffett's berkshire hathaway reveals record $157 billion cash pile as the investor hunts in vain for bargains

Warren Buffett came up short in his search for cheap stocks and businesses last quarter. His company Berkshire Hathaway sold over $5 billion of stocks...

November 4, 2023, 9:47 am

Elliott wave analysis of eurusd – november 6th, 2023

EURUSD gained a lot of ground last week after the Fed kept rates steady and economic data showed inflation was cooling. Can this be the beginning of a...

November 4, 2023, 8:34 am

This 7.6%-yielding dividend stock showcases why it's a no-brainer for income

Enbridge continues to deliver solid results. The company's financial metrics are at the low end of its guidance ranges....

November 4, 2023, 6:27 am

Looking for a lifetime of passive income? 2 top dividend stocks to buy and hold forever

Companies with a track record of dividend increases have shown rewarding shareholders is a priority. If those companies also have strong free cash flo...

November 4, 2023, 5:30 am

Micron is positioned to enjoy the semiconductors next cycle

Micron is an attractive investment opportunity in the information technology sector, operating in the growing semiconductor industry. The company has ...

November 4, 2023, 1:39 am

South korea's exports rebound in october 2023

South Korea's exports to mainland China have remained weak during 2023, recording a decline of 9.5% y/y in October. According to latest trade data fro...

November 4, 2023, 12:04 am

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Replimune presents updated interim results from the artacus clinical trial of rp1 monotherapy in solid organ and hematopoietic cell transplant recipients with skin cancers during oral presentation at

RP1 as monotherapy showed clear anti-tumor activity with an overall response rate of nearly 35 percent in evaluable patients WOBURN, Mass., Nov. 03, 2...

November 3, 2023, 11:30 pm

Fxwirepro: gbp/nzd remains weak, eyes 23.6%fib support

GBP/NZD picked up further downside momentum on Friday after showed U.S. employers added fewer jobs than expected last month. Data showed employers add...

November 3, 2023, 10:29 pm

Ftls: hedge fund strategies in an etf format

First Trust Long/Short Equity ETF is a unique investment vehicle that aims to provide long-term total returns with less volatility than the S&P 500 in...

November 3, 2023, 9:55 pm

Us equity close: largest weekly gain for the nasdaq since november 2022

Closing changes on the day:S&P 500 up +1.00%DJIA +0.7%Russell 2000 +2.7%Nasdaq Comp +1.4%Toronto TSX Comp +1.0%On the week:S&P 500 up 5.9% -- best sin...

November 3, 2023, 8:38 pm


Search within

Pages Search Results: